Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Britta Swebilius Singer is active.

Publication


Featured researches published by Britta Swebilius Singer.


Cell | 2013

Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

Francesco Loffredo; Matthew L. Steinhauser; Steven M. Jay; Joseph Gannon; James R. Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall’Osso; Danika Mei Po Khong; J Shadrach; Christine M. Miller; Britta Swebilius Singer; Alex Stewart; Nikolaos Psychogios; Robert E. Gerszten; Adam J. Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J. Wagers; Richard T. Lee

The most common form of heart failure occurs with normal systolic function and often involves cardiac hypertrophy in the elderly. To clarify the biological mechanisms that drive cardiac hypertrophy in aging, we tested the influence of circulating factors using heterochronic parabiosis, a surgical technique in which joining of animals of different ages leads to a shared circulation. After 4 weeks of exposure to the circulation of young mice, cardiac hypertrophy in old mice dramatically regressed, accompanied by reduced cardiomyocyte size and molecular remodeling. Reversal of age-related hypertrophy was not attributable to hemodynamic or behavioral effects of parabiosis, implicating a blood-borne factor. Using modified aptamer-based proteomics, we identified the TGF-β superfamily member GDF11 as a circulating factor in young mice that declines with age. Treatment of old mice to restore GDF11 to youthful levels recapitulated the effects of parabiosis and reversed age-related hypertrophy, revealing a therapeutic opportunity for cardiac aging.


Journal of Molecular Biology | 1981

rII cistrons of bacteriophage T4: DNA sequence around the intercistronic divide and positions of genetic landmarks☆

David Pribnow; D.Christine Sigurdson; Larry Gold; Britta Swebilius Singer; Carolyn Napoli; Jürgen Brosius; Thomas J. Dull; Harry F. Noller

Abstract An 873 base-pair DNA sequence from the rII region of bacteriophage T4 is presented. The sequence encodes 139 carboxyl-terminal amino acids of rIIA and the amino-terminal 146 amino acids of rIIB. Eleven base-pairs separate the rIIA stop codon (UAA) and the rIIB AUG. An extensive genetic map is superimposed on the DNA sequence, showing the deduced locations of many of the mutations (base-pair substitutions, frameshifts, deletions) found in previous rII genetic studies.


Cell | 1982

Determination of the amount of homology required for recombination in bacteriophage T4

Britta Swebilius Singer; Larry Gold; Peter Gauss; Daniel H. Doherty

Homology is an important feature of recombination. We have used the rll cistrons of bacteriophage T4 to determine the extent of homology required for recombination. We varied the amount of homologous DNA available for recombination in both marker rescue experiments and deletion-by-deletion crosses. Our results suggest that the primary pathway for recombination in T4 requires 50 bp of homology. Our finding that recombination is detectable when fewer than 50 bp of homology are available suggests that there is a second, less efficient pathway of recombination in T4. This pathway may be used during the formation of deletions.


Proceedings of the National Academy of Sciences of the United States of America | 2015

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy

Yetrib Hathout; Edward N. Brody; Paula R. Clemens; Linda H. Cripe; Robert Kirk Delisle; Pat Furlong; Heather Gordish-Dressman; Lauren P. Hache; Erik Henricson; Eric P. Hoffman; Yvonne M. Kobayashi; Angela Lorts; Jean K. Mah; Craig M. McDonald; Bob Mehler; Sally K. Nelson; Malti Nikrad; Britta Swebilius Singer; Fintan Steele; David Sterling; H. Lee Sweeney; Steven Williams; Larry Gold

Significance Duchenne muscular dystrophy (DMD) is a rare and devastating muscle disease caused by mutations in the X-linked DMD gene (which encodes the dystrophin protein). Serum biomarkers hold significant potential as objective phenotypic measures of DMD disease state, as well as potential measures of pharmacological effects of and response to therapeutic interventions. Here we describe a proteomics approach to determine serum levels of 1,125 proteins in 93 DMD patients and 45 controls. The study identified 44 biomarkers that differed significantly between patients and controls. These data are being made available to DMD researchers and clinicians to accelerate the search for new diagnostic, prognostic, and therapeutic approaches. Serum biomarkers in Duchenne muscular dystrophy (DMD) may provide deeper insights into disease pathogenesis, suggest new therapeutic approaches, serve as acute read-outs of drug effects, and be useful as surrogate outcome measures to predict later clinical benefit. In this study a large-scale biomarker discovery was performed on serum samples from patients with DMD and age-matched healthy volunteers using a modified aptamer-based proteomics technology. Levels of 1,125 proteins were quantified in serum samples from two independent DMD cohorts: cohort 1 (The Parent Project Muscular Dystrophy–Cincinnati Children’s Hospital Medical Center), 42 patients with DMD and 28 age-matched normal volunteers; and cohort 2 (The Cooperative International Neuromuscular Research Group, Duchenne Natural History Study), 51 patients with DMD and 17 age-matched normal volunteers. Forty-four proteins showed significant differences that were consistent in both cohorts when comparing DMD patients and healthy volunteers at a 1% false-discovery rate, a large number of significant protein changes for such a small study. These biomarkers can be classified by known cellular processes and by age-dependent changes in protein concentration. Our findings demonstrate both the utility of this unbiased biomarker discovery approach and suggest potential new diagnostic and therapeutic avenues for ameliorating the burden of DMD and, we hope, other rare and devastating diseases.


Journal of Molecular Biology | 1988

Deletion formation in bacteriophage T4

Britta Swebilius Singer; Jane Westlye

We have manipulated the dispensable region of the rIIB gene of bacteriophage T4 in order to study the generation of deletions involving direct repeats. We show that recombination between different parental chromosomes is one source of the deletions we have studied. We have also investigated the effects of structure, base composition and distance on deletion formation. We demonstrate that the potential to form structure in single-stranded DNA has variable effects on the frequency of deletion formation and conclude that, in some cases, slipped mispairing during DNA synthesis can make a substantial contribution to deletion frequencies. The G + C richness of the direct repeats involved in deletion formation is an important parameter of the frequency of deletion formation. We have confirmed that increasing the distance between direct repeats decreases deletion frequency.


Journal of Molecular Biology | 1981

Analysis in vivo of translational mutants of the rIIB cistron of bacteriophage T4

Britta Swebilius Singer; Larry Gold; Sidney Shinedling; Michelle Colkitt; Lawrence R. Hunter; David Pribnow; Mary Nelson

Abstract We have mapped the mutants isolated by Nelson et al. (1981) that reduce the amount of rIIB protein synthesized during bacteriophage T4 infection of Escherichia coli B and characterized their rIIB expression in vivo. These mutants fall into four distinct groups in terms of mapping and phenotype. We have located the probable site of each mutation on the DNA sequence. We have also analyzed a number of other mutations near the initiating AUG of rIIB with respect to their rIIB expression. In some of these mutants, ribosomal recognition of the wild-type initiating AUG is precluded and so initiation occurs at a different AUG, which, in some instances, we have identified.


Journal of Molecular Biology | 1981

Translational reinitiation in the rIIB cistron of bacteriophage T4

Carolyn Napoli; Larry Gold; Britta Swebilius Singer

Abstract During translation of the bacteriophage T4 rIIB gene messenger RNA, premature termination sometimes results in translational reinitiation. The nucleotide sequence surrounding the true initiating AUG of the rIIB message has been determined recently. We have identified potential reinitiation codons within this sequence and determined which of these codons are utilized in reinitiation events. We have used the sequence to reinterpret the x reinitiation event described by Sarabhai & Brenner (1967).


European Heart Journal | 2015

Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts

Kristoff A. Olson; Alexis L. Beatty; Bettina Heidecker; Mathilda Regan; Edward N. Brody; Trudi Foreman; Shintaro Kato; Robert Mehler; Britta Swebilius Singer; Kristian Hveem; Håvard Dalen; David Sterling; Richard M. Lawn; Nelson B. Schiller; Stephen A. Williams; Mary A. Whooley; Peter Ganz

AIMS Growth differentiation factor 11 and/or its homologue growth differentiation factor 8 (GDF11/8) reverses age-related cardiac hypertrophy and vascular ageing in mice. We investigated whether GDF11/8 associates with cardiovascular outcomes, left ventricular hypertrophy (LVH), or age in humans. METHODS AND RESULTS We measured plasma GDF11/8 levels in 928 participants with stable ischaemic heart disease in the Heart and Soul study. We adjudicated heart failure hospitalization, stroke, myocardial infarction, death, and their composite endpoint. Left ventricular hypertrophy was evaluated by echocardiography. We used multivariable Cox proportional hazards models to compare rates of cardiovascular events and death across GDF11/8 quartiles and logistic regression models to evaluate the association between GDF11/8 and LVH. Four hundred and fifty participants (48.5%) experienced a cardiovascular event or death during 8.9 years of follow-up. The adjusted risk of the composite endpoint was lower in the highest compared with the lowest GDF11/8 quartile [hazard ratio (HR), 0.45; 95% confidence interval (CI), 0.33-0.60; P < 0.001]. We replicated this relationship of GDF11/8 to adverse events in 971 participants in the HUNT3 cohort (adjusted HR, 0.34; 95% CI, 0.23-0.51; P < 0.001). Left ventricular hypertrophy was present in 368 participants (39.7%) at baseline. Participants in the highest quartile of GDF11/8 were less likely to have LVH than those in the lowest quartile (adjusted OR, 0.55; 95% CI, 0.35-0.86; P = 0.009). GDF11/8 levels were lower in older individuals (P < 0.001). CONCLUSION In patients with stable ischaemic heart disease, higher GDF11/8 levels are associated with lower risk of cardiovascular events and death. Our findings suggest that GDF11/8 has similar cardioprotective properties in humans to those demonstrated in mice.


Current Opinion in Genetics & Development | 1997

SELEX and the evolution of genomes.

Larry Gold; Britta Swebilius Singer; Yi-yuan He; Ed Brody

The interrupted genome structures of complex multicellular organisms have most likely changed the evolution of the regulation of metabolism and development. Wasted intron sequences make regulation of gene expression in (for example) mammals appear to be unnecessarily complicated. The recent discoveries that globular RNA molecules are very much like the antigen-combining sites of antibodies suggest that intronic RNA may be used to help solve the problems raised by this complexity.


Journal of Molecular Biology | 1976

A mutation that confers temperature sensitivity on the translation of rIIB in bacteriophage T4.

Britta Swebilius Singer; Larry Gold

Abstract HD263 is a recessive temperature-sensitive mutation which maps in the promoter proximal region of the rIIB gene of the bacteriophage T4. Expression of rIIB is temperature-dependent in this mutant strain. No rIIB polypeptide is found in HD263 infections of Escherichia coli B at high temperature, and at low temperature less rIIB polypeptide is found than in equivalent wild-type infections. This accounts for the r -type plaque which HD263 forms when plated on E. coli B at any temperature, and for the inability of HD263 to grow on a lambda lysogen at high temperature. No other differences between HD263 and wild type have been found. Possible mechanisms to account for the temperature sensitivity of HD263 have been considered. Temperature-sensitive transcription has been ruled out. Degradation of HD263 rIIB polypeptide has been impossible to detect at any temperature. This suggests that the translatability of HD263 rIIB mRNA is temperature-dependent. A revertant of HD263 which is no longer temperature-sensitive but which produces limited quantities of rIIB polypeptide is discussed. The properties of this revertant are consistent with a translational model for the temperature sensitivity of HD263.

Collaboration


Dive into the Britta Swebilius Singer's collaboration.

Top Co-Authors

Avatar

Larry Gold

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

Edward N. Brody

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

David Pribnow

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

David Sterling

University of California

View shared research outputs
Top Co-Authors

Avatar

Bruce E. Eaton

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

Sidney Shinedling

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

Timur Shtatland

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

Angela Lorts

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Brian Hicke

University of Colorado Boulder

View shared research outputs
Researchain Logo
Decentralizing Knowledge